New shot tested for stubborn arthritis pain
NCT ID NCT07245992
Summary
This early-stage study is testing the safety of a new drug called F8IL10, which is injected directly into an inflamed joint. Researchers want to find the highest dose that is safe and well-tolerated in adults with rheumatoid arthritis who still have flare-ups despite their regular medications. The main goal is to determine the best dose for future studies, while also checking for any early signs that the injection might help reduce joint pain and swelling.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arcispedale Santa Maria Nuova
NOT_YET_RECRUITINGReggio Emilia, Reggio Emilia, 42123, Italy
Contact
-
Azienda Ospedaliera Universitaria Integrata Verona c/o Policlinico GB Rossi (Borgo Roma), Dep. Reumatologia
RECRUITINGVerona, VR, 37134, Italy
Contact
Conditions
Explore the condition pages connected to this study.